Inergetics Discovers Unique Combination of Cannabinoids for New Product Line as it Exits Phase II of R&D and Prepares for Final Development Phase

NEWARK, N.J., Sept. 24, 2014 /PRNewswire via COMTEX/ Inergetics, Inc. (OTCBB: NRTI), a leading developer of nutritional supplements, today announced that it has identified and procured a non-cannabis source of an important cannabinoid that will be incorporated into its initial first to market combination cannabinoid product line to provide additional synergistic benefits in terms of overall efficacy and absorption. With direction from our Scientific/Medical Advisory Board and strategic relationships we have developed internationally, Inergetics has sourced and procured a novel non-cannabis cannabinoid to work side-by-side with CBD, states Chief Science Officer Carl Germano, RD, CNS, CDN. This additional cannabinoid from a non-cannabis source is a perfect companion to our CBD ingredient as it targets receptors in the body that help control inflammation and pain signaling. By bringing these two important cannabinoids together, our first nutraceutical CBD product line is capable of feed
http://bit.ly/1ohMUbe